CADL
Candel Therapeutics Inc.
$5.38
-$0.20(-3.58%)
43
Overall
60
Value
40
Tech
31
Quality
Market Cap
$307.41M
Volume
837.42K
52W Range
$3.79 - $14.60
Target Price
$20.17
EPS Estimates Overview
| Current Quarter | $-0.18 | Next Quarter | $-0.23 |
| Current Year | $-0.4 | Next Year | $-0.48 |
| QoQ Growth | -27.8% | YoY Growth | -20.0% |
| 3Y EPS CAGR | +3.1% | Target Price | $20.17 |
| Consensus | Buy | Upside | +274.9% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CADL | $5.38 | -3.6% | 837.42K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Candel Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW